Maines Choice - Preferred HMO
Harvard Pilgrim Health Care PPO
Harvard Pilgrim Health Care HMO
Dr. Kathryn Hurst, MD
Developmental-Behavioral Pediatrics*
Age 41
Be the first to review this provider!
Offers telehealth
Link Copied!
Profile link copied to clipboard!
Link Copied!
Profile link copied to clipboard!
Dr. Kathryn Hurst, MD
Be the first to review this provider!
Portland, ME
Accepting new patients
Offers telehealth
Clinical Overview
Dr. Kathryn Hurst, MD works in Portland, ME as
Offers Telehealth
This provider offers telehealth appointments. Call the office to schedule.
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Blue Card PPO
-
First Health (Coventry Health Care) PPO
-
Pathway-ME HMOBlue Choice-ME PPOPathway Enhanced-ME POSMaine HMO
-
Options PPOMedica ChoiceNavigate HMONavigate POSNexus Open AccessChoice Plus POS
-
Tufts PPO
-
Blue Cross Blue Shield of Massachusetts PPO
-
Choice Plus POS IIElect Choice (Open Access) EPOPremier Care Network Plus - Innovation HealthOpen Choice PPOSelectManaged Choice (Open Access) POSAetna
-
Curative PPO PlusCurative EPOCurative PPO
Office Locations
-
Office1577 Congress St Ste 2, Portland, ME 04102
-
Office3550 Market St Fl 3, Philadelphia, PA 19104
-
Office1577 W Commercial St Fl 2, Portland, ME 04102
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Hurst?
Step 1 of 3
Your review of Dr. Kathryn Hurst, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Developmental-Behavioral Pediatrics
Pediatrics
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Kathryn Hurst, MD accepts new patients on Medical News Today.
Dr. Hurst accepts telehealth appointments. Please call Dr. Hurst's office to make an appointment.
Dr. Hurst accepts Harvard Pilgrim Health Care, Blue Cross Blue Shield, First Health, Anthem, UnitedHealthCare, Tufts Health Plan, Blue Cross and Blue Shield of Massachusetts, Aetna and Curative as well as many others. See all of the insurances Dr. Hurst accepts here.
Dr. Hurst's office is located at 1577 Congress St Ste 2 Portland, ME 04102. Get a map and directions to Dr. Hurst's office here.
Dr. Hurst frequently sees patients for
Dr. Hurst does not have any reviews yet.
Dr. Hurst is board certified in
Education & Credentials
Medical Education
- Saba University School of Medicine
Board Certifications
- Developmental & Behavioral Pediatrics and Pediatrics
Claim Your Profile
Are you Dr. Kathryn Hurst, MD?
Telehealth Options
This provider has not specified a telehealth appointment method. Would you still like to make an appointment with Dr. Hurst?
Affiliated Hospitals & Medical Centers
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A real world study suggests found that more than three-quarters of participants receiving the anti-amyloid drug Leqembi either remained clinically stable or improved by one disease stage.
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Up to 45% of dementia cases globally could be delayed or even prevented by acting on modifiable risk factors, new WHO guidelines show.
